Literature DB >> 11781830

Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer.

B Zhao1, G Bepler.   

Abstract

Molecular, functional, and clinical analyses strongly suggest that chromosome segment 11p15.5 contains a gene involved in lung cancer pathogenesis. The critical region of allele loss is 310 kb in size. We used our contig of P1-phage artificial chromosome (PAC) clones together with newly identified bacterial artificial chromosome (BAC) clones and the draft human genome sequence to complete a contiguous string of 380 407 bp. Three PAC clones that span the region were used to identify transcripts by exon trapping. Computational gene prediction algorithms were used to query the sequence for potential genes and exons. Screening for expression was performed with tissue-specific and cell line derived mRNA arrays. The region contains the complete SSA/Ro52 and RRM1 genes, exons 7-12 of the GOK gene, and the psirad pseudo-gene. A cluster of six nearly identical genes with an intact open reading frame (ORF) of 585 bp that share 75% identity with the HSPC182 gene was found. In addition, five putative novel genes were identified. Sequence tagged sites (STS) and polymorphic markers were used to screen 117 lung cancer cell lines for homozygous deletions and none were identified. These data provide the basis for the identification of a lung cancer suppressor gene on 11p15.5.

Entities:  

Mesh:

Year:  2001        PMID: 11781830     DOI: 10.1038/sj.onc.1205027

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Polymorphisms in CARS are associated with gastric cancer risk: a two-stage case-control study in the Chinese population.

Authors:  Tian Tian; Ling Xiao; Jiangbo Du; Xun Zhu; Yayun Gu; Na Qin; Caiwang Yan; Li Liu; Hongxia Ma; Yue Jiang; Jiaping Chen; Hao Yu; Juncheng Dai
Journal:  Gastric Cancer       Date:  2017-04-13       Impact factor: 7.370

2.  Pharmacogenomics: a reality or still a promise?

Authors:  Gerold Bepler
Journal:  Lung Cancer       Date:  2006-10-24       Impact factor: 5.705

3.  The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.

Authors:  S Brauner; M Ivanchenko; G E Thorlacius; A Ambrosi; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2018-10-16       Impact factor: 4.330

Review 4.  Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?

Authors:  Zohreh Tatari-Calderone; Naomi L C Luban; Stanislav Vukmanovic
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

5.  TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis.

Authors:  Ji-An Pan; Yu Sun; Ya-Ping Jiang; Alex J Bott; Nadia Jaber; Zhixun Dou; Bin Yang; Juei-Suei Chen; Joseph M Catanzaro; Chunying Du; Wen-Xing Ding; Maria T Diaz-Meco; Jorge Moscat; Keiko Ozato; Richard Z Lin; Wei-Xing Zong
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

6.  Loss of heterozygosity of TRIM3 in malignant gliomas.

Authors:  Jean-Louis Boulay; Urs Stiefel; Elisabeth Taylor; Béatrice Dolder; Adrian Merlo; Frank Hirth
Journal:  BMC Cancer       Date:  2009-02-27       Impact factor: 4.430

7.  PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling.

Authors:  Xiaoqi Wang; Guangyuan Li; Sanjay Koul; Rieko Ohki; Matthew Maurer; Alain Borczuk; Balazs Halmos
Journal:  Oncotarget       Date:  2015-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.